Advanced Net Receivables from 2010 to 2026
| ADVB Stock | 0.24 0.01 2.08% |
Net Receivables | First Reported 2010-12-31 | Previous Quarter 7.2 K | Current Value 6.8 K | Quarterly Volatility 39 K |
Check Advanced Biomed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Advanced Biomed's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 64.6 K or Interest Income of 64.6 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.0048. Advanced financial statements analysis is a perfect complement when working with Advanced Biomed Valuation or Volatility modules.
Advanced | Net Receivables | Build AI portfolio with Advanced Stock |
Analyzing Advanced Biomed's Net Receivables over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Receivables has evolved provides context for assessing Advanced Biomed's current valuation and future prospects.
Latest Advanced Biomed's Net Receivables Growth Pattern
Below is the plot of the Net Receivables of Advanced Biomed Common over the last few years. It is Advanced Biomed's Net Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Advanced Biomed's overall financial position and show how it may be relating to other accounts over time.
| Net Receivables | 10 Years Trend |
|
Net Receivables |
| Timeline |
Advanced Net Receivables Regression Statistics
| Arithmetic Mean | 11,776 | |
| Geometric Mean | 1,334 | |
| Coefficient Of Variation | 330.82 | |
| Mean Deviation | 17,734 | |
| Median | 419.00 | |
| Standard Deviation | 38,956 | |
| Sample Variance | 1.5B | |
| Range | 162.1K | |
| R-Value | 0.22 | |
| Mean Square Error | 1.5B | |
| R-Squared | 0.05 | |
| Significance | 0.41 | |
| Slope | 1,659 | |
| Total Sum of Squares | 24.3B |
Advanced Net Receivables History
About Advanced Biomed Financial Statements
Advanced Biomed stakeholders use historical fundamental indicators, such as Advanced Biomed's Net Receivables, to determine how well the company is positioned to perform in the future. Although Advanced Biomed investors may analyze each financial statement separately, they are all interrelated. For example, changes in Advanced Biomed's assets and liabilities are reflected in the revenues and expenses on Advanced Biomed's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Advanced Biomed Common. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Receivables | 7.2 K | 6.8 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Advanced Biomed Common offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Advanced Biomed's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Advanced Biomed Common Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Advanced Biomed Common Stock:Check out the analysis of Advanced Biomed Correlation against competitors. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Advanced Biomed. If investors know Advanced will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Advanced Biomed assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Understanding Advanced Biomed Common requires distinguishing between market price and book value, where the latter reflects Advanced's accounting equity. The concept of intrinsic value - what Advanced Biomed's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Advanced Biomed's price substantially above or below its fundamental value.
Understanding that Advanced Biomed's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Advanced Biomed represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Advanced Biomed's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.